Literature DB >> 18725077

Cachexia and neuropeptide Y.

John E Morley1, Susan A Farr.   

Abstract

Cachexia or wasting disease occurs commonly in diseases that have an overproduction of proinflammatory cytokines associated with them. The hallmarks of cachexia are loss of lean and adipose tissue, anorexia, anemia, memory disturbance, and sickness behavior. This review suggests that increased inducible nitric oxide synthase production in the hypothalamus leads to severe anorexia and that this is the pathway through which proinflammatory cytokines produce anorexia. Orexigenic peptides, such as neuropeptide, ghrelin, and orexin A, and anorectic peptides, such as leptin, produce their effects through neuronal nitric oxide synthase. Activation of neuronal nitric oxide synthase results in increased adenosine monophosphate kinase and a decrease in malonyl coenzyme A, leading to increased food intake.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725077     DOI: 10.1016/j.nut.2008.06.020

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  10 in total

1.  Cachexia - an intrinsic factor in wound healing.

Authors:  Michael F Y Ng
Journal:  Int Wound J       Date:  2010-04       Impact factor: 3.315

2.  Neuropeptide Y levels are associated with nutritional status and cardiovascular events in adults with chronic kidney disease.

Authors:  L Lu; Y-C Zou; M Wang; Y-F Huang; D-X Chen; L-B Wei
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

Review 3.  Pathophysiology and treatment options for cardiac anorexia.

Authors:  Marat Fudim; Gabriel Wagman; Rebecca Altschul; Evin Yucel; Michelle Bloom; Timothy J Vittorio
Journal:  Curr Heart Fail Rep       Date:  2011-06

4.  Micellar nanomedicine of human neuropeptide Y.

Authors:  Antonina Kuzmis; Sok Bee Lim; Esha Desai; Eunjung Jeon; Bao-Shiang Lee; Israel Rubinstein; Hayat Onyüksel
Journal:  Nanomedicine       Date:  2011-01-25       Impact factor: 5.307

5.  Ghrelin for cachexia.

Authors:  Takashi Akamizu; Kenji Kangawa
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

Review 6.  Glucose sensing neurons in the ventromedial hypothalamus.

Authors:  Vanessa H Routh
Journal:  Sensors (Basel)       Date:  2010       Impact factor: 3.576

7.  Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia.

Authors:  John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-04-27       Impact factor: 12.910

Review 8.  Sarcopenia: assessment of disease burden and strategies to improve outcomes.

Authors:  Ilaria Liguori; Gennaro Russo; Luisa Aran; Giulia Bulli; Francesco Curcio; David Della-Morte; Gaetano Gargiulo; Gianluca Testa; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Clin Interv Aging       Date:  2018-05-14       Impact factor: 4.458

9.  The effect of enteral and parenteral feeding on secretion of orexigenic peptides in infants.

Authors:  Przemyslaw J Tomasik; Krystyna Sztefko
Journal:  BMC Gastroenterol       Date:  2009-12-10       Impact factor: 3.067

10.  Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.

Authors:  N Fujitsuka; A Asakawa; Y Uezono; K Minami; T Yamaguchi; A Niijima; T Yada; Y Maejima; U Sedbazar; T Sakai; T Hattori; Y Kase; A Inui
Journal:  Transl Psychiatry       Date:  2011-07-26       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.